Free Trial

Zimmer Biomet (ZBH) Earnings Date, Estimates & Call Transcripts

Zimmer Biomet logo
$102.30 +0.04 (+0.04%)
Closing price 04/11/2025 03:59 PM Eastern
Extended Trading
$101.45 -0.85 (-0.83%)
As of 04/11/2025 04:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Zimmer Biomet Earnings Summary

Upcoming
Earnings Date
May. 5Before Market OpensEstimated
Consensus EPS
(Feb. 6)
$2.30
Actual EPS
(Feb. 6)
$2.31 Beat By $0.01

Zimmer Biomet posted Q4 2024 earnings on February 6, 2025, reporting an EPS of $2.31, which topped the consensus estimate of $2.30 by $0.01. With a trailing EPS of $4.45 and a P/E Ratio of 22.99, Zimmer Biomet's earnings are expected to grow 7.91% next year, from $8.22 to $8.87 per share.

Q4 2024 Earnings Resources

ZBH Upcoming Earnings

Zimmer Biomet's Q1 2025 earnings is scheduled for Monday, May 5, 2025, with a conference call scheduled at 8:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get Zimmer Biomet Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Zimmer Biomet and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ZBH Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ZBH Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.
Remove Ads

Zimmer Biomet Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20252$1.75$1.77$1.76 
Q2 20252$2.03$2.04$2.04 
Q3 20252$1.93$2.01$1.97 
Q4 20252$2.41$2.49$2.45 
FY 20258$8.12$8.31$8.22 
Q1 20261$2.12$2.12$2.12 
Q2 20261$2.23$2.23$2.23 
Q3 20261$2.15$2.15$2.15 
Q4 20261$2.30$2.30$2.30 
FY 20264$8.80$8.80$8.80 
Q1 20271$2.25$2.25$2.25 
Remove Ads

Zimmer Biomet Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/5/2025
(Estimated)
-------
2/6/2025Q4 2024$2.30$2.31+$0.01$1.20$2.01B-
10/30/2024Q3 2024$1.74$1.74-$2.25$1.80B$1.82B
8/7/2024Q2 2024$1.99$2.01+$0.02$2.84$1.94B$1.94B
5/2/2024Q1 2024$1.87$1.94+$0.07$3.04$1.87B$1.89B
2/8/2024Q4 2023$2.15$2.20+$0.05$2.39$1.93B$1.94B
11/7/2023Q3 2023$1.59$1.65+$0.06$2.53$1.75B$1.75B
8/1/2023Q2 2023$1.82$1.82-$2.64$1.83B$1.87B
5/2/2023Q1 2023$1.64$1.89+$0.25$2.67$1.70B$1.83B

Zimmer Biomet Earnings - Frequently Asked Questions

Zimmer Biomet has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 5th, 2025 based off last year's report dates. Learn more on ZBH's earnings history.

Zimmer Biomet updated its FY 2025 earnings guidance on Thursday, February, 6th. The company provided earnings per share (EPS) guidance of 8.150-8.350 for the period, compared to the consensus estimate of 8.550. The company issued revenue guidance of $7.8 billion-$7.9 billion, compared to the consensus revenue estimate of $8.0 billion.

In the previous quarter, Zimmer Biomet (NYSE:ZBH) reported $2.31 earnings per share (EPS) to beat the analysts' consensus estimate of $2.30 by $0.01. Learn more on analysts' earnings estimate vs. ZBH's actual earnings.

The conference call for Zimmer Biomet's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Zimmer Biomet's latest earnings report can be read online.
Read Transcript

Zimmer Biomet (NYSE:ZBH) has a recorded annual revenue of $7.68 billion.

Zimmer Biomet (NYSE:ZBH) has a recorded net income of $903.70 million. ZBH has generated $4.45 earnings per share over the last four quarters.

Zimmer Biomet (NYSE:ZBH) has a trailing price-to-earnings ratio of 22.99 and a forward price-to-earnings ratio of 12.44. The price/earnings-to-growth ratio is 1.95.

Zimmer Biomet's earnings are expected to grow from $8.22 per share to $8.87 per share in the next year, which is a 7.91% increase.

More Earnings Resources from MarketBeat

Remove Ads


This page (NYSE:ZBH) was last updated on 4/13/2025 by MarketBeat.com Staff
From Our Partners